MSB 4.39% $1.09 mesoblast limited

Ann: COVID-19/GVHD Update, Quarterly Report and Appendix 4C, page-225

  1. 4,123 Posts.
    lightbulb Created with Sketch. 5355
    Highly doubtful. If they didn't have enough to serve a measly 300 people , how could they claim to the FDA to have any stockpile of Ryoncil on Sep 30 approval to allow immediate treatment, I think that is a pre-requisite of approval.

    Now that they are moving the manufacturing into one of the US labs, that also has a couple of massive - 2000 and 1000 liter bioreactors.... getting enough treatment is not going to be an issue - it has never been identified by the company as being an issue. They pay lonza, and lonza produce. ?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.050(4.39%)
Mkt cap ! $1.244B
Open High Low Value Volume
$1.14 $1.17 $1.07 $8.385M 7.489M

Buyers (Bids)

No. Vol. Price($)
1 8500 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 26954 3
View Market Depth
Last trade - 16.10pm 19/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.